235 related articles for article (PubMed ID: 36863097)
1. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
Chang TT; Li SY; Lin LY; Chen C; Chen JW
Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
[TBL] [Abstract][Full Text] [Related]
2. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
3. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
Lin Y; Shao Z; Zhao M; Li J; Xu X
Biochem Biophys Res Commun; 2021 Apr; 550():62-69. PubMed ID: 33684622
[TBL] [Abstract][Full Text] [Related]
4. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
[TBL] [Abstract][Full Text] [Related]
6. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
[TBL] [Abstract][Full Text] [Related]
8. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
Jin J; Ye M; Hu K; Gong J; He Q
Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
[TBL] [Abstract][Full Text] [Related]
9. Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling.
Chen X; Tan H; Xu J; Tian Y; Yuan Q; Zuo Y; Chen Q; Hong X; Fu H; Hou FF; Zhou L; Liu Y
Kidney Int; 2022 Sep; 102(3):506-520. PubMed ID: 35644285
[TBL] [Abstract][Full Text] [Related]
10. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
Wei TT; Yang LT; Guo F; Tao SB; Cheng L; Huang RS; Ma L; Fu P
Acta Pharmacol Sin; 2021 Feb; 42(2):252-263. PubMed ID: 32948825
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
13. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
14. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.
Gong M; Guo Y; Dong H; Wu F; He Q; Gong J; Lu F
Phytomedicine; 2024 Jan; 123():155247. PubMed ID: 38128393
[TBL] [Abstract][Full Text] [Related]
15. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
Diabetologia; 2024 Jun; ():. PubMed ID: 38879617
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
[TBL] [Abstract][Full Text] [Related]
17. PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
Zhang L; Liu J; Zhou F; Wang W; Chen N
Mol Med Rep; 2018 Mar; 17(3):4490-4498. PubMed ID: 29344670
[TBL] [Abstract][Full Text] [Related]
18. Podocyte derived TNF-α mediates monocyte differentiation and contributes to glomerular injury.
Nishad R; Mukhi D; Kethavath S; Raviraj S; Paturi ASV; Motrapu M; Kurukuti S; Pasupulati AK
FASEB J; 2022 Dec; 36(12):e22622. PubMed ID: 36421039
[TBL] [Abstract][Full Text] [Related]
19. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
[TBL] [Abstract][Full Text] [Related]
20. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
